Skip to main content
. 2022 Oct 31;149(8):4959–4965. doi: 10.1007/s00432-022-04404-4

Table 3.

PPU review

Region Randomised participants (n =) PPU’s participants* n (%) Results of central PPU review
Unblinded after PD confirmed
n = (%)
Unblinded after treatment ended—other reason
n = (%)
ANZ 81 46 (57) 42 (91) 4 (9)
Korea 54 29 (54) 29 (100) 0 (0)
Canada 17 11 (65) 11 (100) 0 (0)
Global 152 86 (57) 82 (95) 4 (5)